Medical research

Researchers find new rhinovirus infection insights

(Medical Xpress)—On average, each of us catches a cold two to three times a year. However, how the common cold virus actually infects us is only partly understood. Researchers from the Max F. Perutz Laboratories of the ...

Medical research

Model virus structure shows why there's no cure for common cold

In a pair of landmark studies that exploit the genetic sequencing of the "missing link" cold virus, rhinovirus C, scientists at the University of Wisconsin-Madison have constructed a three-dimensional model of the pathogen ...

HIV & AIDS

'Gap' for HIV vaccine efforts after latest setback

The hunt for an HIV vaccine has gobbled up $8 billion in the past decade, and the failure of the most recent efficacy trial has delivered yet another setback to 26 years of efforts.

Psychology & Psychiatry

Cocaine vaccine passes key testing hurdle

Researchers at Weill Cornell Medical College have successfully tested their novel anti-cocaine vaccine in primates, bringing them closer to launching human clinical trials. Their study, published online by the journal Neuropsychopharmacology, ...

Diseases, Conditions, Syndromes

Saudi Arabia reports three cases of SARS-like virus

Saudi Arabia's Health Ministry has confirmed three more cases of a new respiratory virus related to SARS, bringing to 10 the number of cases it reported this week, including five deadly ones.

Parkinson's & Movement disorders

Study shows how Parkinson's disease protein acts like a virus

A protein known to be a key player in the development of Parkinson's disease is able to enter and harm cells in the same way that viruses do, according to a Loyola University Chicago Stritch School of Medicine study.

Medical research

Blame common colds on your chromosome 'Caps?'

(HealthDay)—Some people seem to catch a cold every few weeks while others appear immune. Now a preliminary study suggests that the protective "caps" on your chromosomes could partly explain the mystery.

Diseases, Conditions, Syndromes

Novel coronavirus well-adapted to humans, susceptible to immunotherapy

The new coronavirus that has emerged in the Middle East is well-adapted to infecting humans but could potentially be treated with immunotherapy, according to a study to be published on February 19 in mBio, the online open-access ...

page 9 from 12